Connect with us

Business

Medipharm Labs Corp (OTCMKTS:MEDIF) Launches its New CBD50 Plus Formula

Published

on

Medipharm Labs Corp (OTCMKTS:MEDIF) has launched its CBD50 Plus Formula (“CBD50”), in a move aimed at accelerating its growth of pharma-quality product portfolio. CBD50 Plus is uniquely formulated; high potency oil mainly used for medical and adult use. Medipharm Labs specializes in the production of pharmaceutical-quality cannabis extraction, derivative and distillation products.

Medipharm Labs Corp Seeking to differentiated cannabis derivative products

MediPharm Labs is using its expertise, and proven platform to distribute its white label product portfolio as well as develop its own in-house Cannabis 2.0 brands.  The company is committed to offering consumers with differentiated cannabis derivative products. MediPharm Labs Chief Executive Officer Pat McCutcheon said they are working to position the company as a market leader in offering well-defined Cannabis 2.0 categories. He added that to achieve this, they will utilize the company’s internal means and growing white-label supply business.  According to McCutcheon, the new product, together with its partnerships, is a clear demonstration of how hard the company is working to realize its ambitions and shift its focus towards commercializing and distributing a larger portfolio of high-quality products.

MediPharm Labs has enough capacity to produce tailored solutions and formulations to its CPG customers and Licensed Producers who serve all the four product categories under  Schedule 4 of the Cannabis Act. These are cannabis topicals, edible cannabis, cannabis extracts, and cannabis oils. The huge exposure to Cannabis 2.0 categories is very important in strengthening the business.

MediPharm Labs Reports First Quarter 2020 Results

MediPharm Labs has announced its financial results for the three months ended March 31, 2020. Besides, the company issued an update on its plans to implement its global Good Manufacturing Practices. In addition, MediPharm Labs is working on certified production platforms plus new international wellness, medicinal, and adult use-recreational products. The company is quirkily evolving and capitalizing on its multi-jurisdictional GMP-certified manufacturing footprint to build a diversified international customer portfolio. This is achieved by exploring multiple product streams suitable for lawful wellness, medicinal, and adult-use recreational markets around the world. According to McCutcheon, the company’s main focus is innovation, capital investment, a pharmaceutical approach, and very high standards achieved through the GMP certification of its Canadian and Australian facilities.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business1 day ago

Business intelligence from Akerna Corp (NASDAQ:KERN) Says Liquor Sales are Up 10% Year-over-Year

Post Views: 334 Liquor sales are up 10% year-over-year according to business intelligence from Akerna Corp (NASDAQ:KERN). Red wine took...

Business1 day ago

Pyxis Tankers Inc. (NASDAQ:PXS) Announce Q1 2020 Financial Results Amid COVID-19 Uncertainties

Post Views: 179 Pyxis tankers Inc. (NASDAQ:PXS) has announced its unaudited financial results for the quarter that ended March 31,...

Business1 day ago

Innovative Industrial Properties Inc (NYSE:IIPR) Enters Into a Lease Amendment Agreement with Green Leaf

Post Views: 197 With pot being legalized in many countries, the market is likely to get even bigger. As a...

Business1 day ago

Liberty Leaf Holdings Ltd (OTCMKTS:LIBFD) Takes Over Nova Mentis Biotech Corp And Add Synergies To Its Cannabis Assets In The Wellness And Health Sector

Post Views: 202 Liberty Leaf Holdings Ltd (OTCMKTS:LIBFD) gained access to the psilocybin by acquiring Nova Mentis Biotech Corp. The...

Business2 days ago

Aleafia Health Inc (OTCMKTS:ALEAF) Begins Cultivation At Its Entire Niagara Facility And Provides Consistent Supplies for Health: Settles Disputes With Aphria

Post Views: 321 Aleafia Health Inc (OTCMKTS:ALEAF) will commence cultivation operations at its whole Niagara facility. It obtained a license...

Business2 days ago

Pure Capital Calls For Shareholders Meeting of Therapix Biosciences Ltd (NASDAQ:TRPX): Demands For Dismissal Of Board Members

Post Views: 253 Pure Capital called for an emergency meeting of investors of Therapix Biosciences Ltd (NASDAQ:TRPX) to discuss actions...